Total neoadjuvant therapy demonstrates consistent real-world efficacy across regimens in patients with locally advanced rectal cancer, a study finds.

A study from Fred Hutch Cancer Center finds that some cancer patients' antibodies can boost their response to immunotherapy treatment.

Researchers have discovered how a hormone interacts with a receptor on the surface of immune cells to shield cancer cells from the body’s natural defenses.

A new study has revealed that autoantibodies—immune proteins traditionally associated with autoimmune disease—may profoundly influence how cancer patients respond to immunotherapy.

Response-Adapted Surgical and Radiotherapy De-Escalation in Resectable Cutaneous Squamous Cell Cancer Using Pembrolizumab: The De-Squamate Study The following represents disclosure information ...

A new study by a Tulane University researcher casts doubt on a widely used shortcut in rectal cancer drug trials, raising concerns that some treatments may be fast-tracked for approval without ...

Bowel cancer symptoms The gastroenterologist, who goes by @thestomachdoc on Instagram, listed 4 symptoms of bowel cancer and the reason why keeping an eye out for them matters.

Clinicians should not recommend ALND for patients with early-stage breast cancer who do not have nodal metastases, and clinicians should not recommend ALND for patients with early-stage breast cancer ...

Using blood samples collected from patients and healthy individuals, the REAP analyses revealed that cancer patients had substantially higher levels of autoantibodies compared to healthy controls.